Investor's Calendar

April 2024

Mon Tue Wed Thu Fri Sat Sun
1
2
3
4
5
6
7
 
 
 
 
 
 
 
8
9
10
11
12
13
14
 
 
 
 
 
 
 
15
16
17
18
19
20
21
 
 
 
 
 
 
 
22
23
24
25
26
27
28
 
 
 
 
 
 
 
29
30
1
2
3
4
5
 
 
 
 
 
 
 

Next Events

  • Jul, 31 2024
    First half 2024 Financial Results

    ROVI will release its First Half 2024 Financial Results on the 31st July, before the opening of the Stock Markets....

See more

Last News

First three months 2024 results press release
ROVI closes the quarter with operating revenue of 151.2 million euros
4 min
08 May, 2024
ROVI announces agreement to manufacture pre-filled syringes
Agreement to manufacture pre-filled syringes for a global pharmaceutical company
3 min
25 Apr, 2024
ROVI receives the FDA’s approval of Risvan® as a treatment for schizophrenia
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
4 min
02 Apr, 2024

See more

Financial and Business Information

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email

ir@rovi.es